Followers | 1076 |
Posts | 26372 |
Boards Moderated | 12 |
Alias Born | 01/11/2016 |
Thursday, August 10, 2023 11:56:01 AM
Recent PRFX News
- PainReform Announces Closing of $4 Million Public Offering • GlobeNewswire Inc. • 04/18/2024 06:19:23 PM
- PainReform Announces Pricing of $4 Million Public Offering • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions • GlobeNewswire Inc. • 04/09/2024 01:00:00 PM
- PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 10:25:16 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 03/01/2024 09:34:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/01/2024 01:09:46 PM
- PainReform Provides Year-End Business Update • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/29/2024 09:37:40 PM
- PainReform to Present at the Microcap Conference in Atlantic City • GlobeNewswire Inc. • 01/22/2024 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/22/2024 05:15:25 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 09:30:32 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 01/12/2024 09:15:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/03/2024 01:36:41 PM
- PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/27/2023 09:04:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/27/2023 09:01:41 PM
- PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds • GlobeNewswire Inc. • 12/26/2023 11:00:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/15/2023 09:09:02 PM
- PainReform Provides Business Update for the Third Quarter of 2023 • GlobeNewswire Inc. • 11/15/2023 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2023 12:41:38 PM
- PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File • GlobeNewswire Inc. • 09/11/2023 12:30:00 PM
- PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary • GlobeNewswire Inc. • 09/07/2023 02:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/05/2023 08:16:34 PM
- PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City • GlobeNewswire Inc. • 09/05/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM